Devinder Singh

1.7k total citations
54 papers, 1.2k citations indexed

About

Devinder Singh is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Nephrology. According to data from OpenAlex, Devinder Singh has authored 54 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cardiology and Cardiovascular Medicine, 16 papers in Surgery and 8 papers in Nephrology. Recurrent topics in Devinder Singh's work include Cardiac Arrhythmias and Treatments (8 papers), Cardiac pacing and defibrillation studies (5 papers) and Cardiac Structural Anomalies and Repair (5 papers). Devinder Singh is often cited by papers focused on Cardiac Arrhythmias and Treatments (8 papers), Cardiac pacing and defibrillation studies (5 papers) and Cardiac Structural Anomalies and Repair (5 papers). Devinder Singh collaborates with scholars based in India, Singapore and United States. Devinder Singh's co-authors include Kanwaljit Chopra, Vikas Chander, Neetu Saini, Rajat Sandhir, Man‐Wen Tian, Srinivasan Murali, Ashis Tayal, S. C. Jones, Jon Brillman and David G. Wright and has published in prestigious journals such as Blood, Neurology and Critical Care Medicine.

In The Last Decade

Devinder Singh

49 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Devinder Singh India 19 299 185 174 147 143 54 1.2k
Robert W. Brock United States 20 204 0.7× 302 1.6× 192 1.1× 118 0.8× 211 1.5× 40 1.2k
Abdullah Nabi Aslan Türkiye 19 231 0.8× 219 1.2× 140 0.8× 77 0.5× 158 1.1× 105 1.3k
Özer Şehırlı Türkiye 26 133 0.4× 321 1.7× 160 0.9× 124 0.8× 133 0.9× 42 1.6k
Murat Yağmurca Türkiye 22 239 0.8× 276 1.5× 130 0.7× 118 0.8× 41 0.3× 31 1.6k
Masato Nishiwaki Japan 20 364 1.2× 178 1.0× 310 1.8× 208 1.4× 112 0.8× 66 1.5k
Kristopher G. Maier United States 25 344 1.2× 438 2.4× 299 1.7× 62 0.4× 152 1.1× 58 1.9k
Young Seol Kim South Korea 29 217 0.7× 568 3.1× 361 2.1× 109 0.7× 308 2.2× 106 2.4k
Salma Malik India 21 126 0.4× 381 2.1× 116 0.7× 275 1.9× 157 1.1× 43 1.4k
Fung Ping Leung Hong Kong 22 338 1.1× 407 2.2× 139 0.8× 114 0.8× 86 0.6× 43 1.5k
Carla S. Ceron Brazil 26 527 1.8× 261 1.4× 184 1.1× 77 0.5× 66 0.5× 60 1.5k

Countries citing papers authored by Devinder Singh

Since Specialization
Citations

This map shows the geographic impact of Devinder Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devinder Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devinder Singh more than expected).

Fields of papers citing papers by Devinder Singh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Devinder Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devinder Singh. The network helps show where Devinder Singh may publish in the future.

Co-authorship network of co-authors of Devinder Singh

This figure shows the co-authorship network connecting the top 25 collaborators of Devinder Singh. A scholar is included among the top collaborators of Devinder Singh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Devinder Singh. Devinder Singh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Lin, Weiqin, et al.. (2022). Ventricular tachycardia from myocarditis following COVID‐19 vaccination with tozinameran (BNT162b2, Pfizer‐BioNTech). Pacing and Clinical Electrophysiology. 45(9). 1097–1100. 5 indexed citations
3.
Tan, Eugene S.J., Siew Pang Chan, Devinder Singh, et al.. (2019). Effect of Diabetes Mellitus on Cardiac Resynchronization Therapy and to Prognosis in Heart Failure (from the Prospective Evaluation of Asian With Cardiac Resynchronization Therapy for Heart Failure Study). The American Journal of Cardiology. 124(6). 899–906. 8 indexed citations
4.
Yip, A.M., et al.. (2019). Magnetic resonance imaging of dilated cardiomyopathy: prognostic benefit of identifying late gadolinium enhancement in Asian patients. Singapore Medical Journal. 62(7). 347–352. 4 indexed citations
5.
Dalakoti, Mayank, et al.. (2019). Electrocardiography findings and clinical presentation in Ebstein’s anomaly. Singapore Medical Journal. 60(11). 560–565. 1 indexed citations
6.
Boey, Elaine, Eugene S.J. Tan, Devinder Singh, et al.. (2019). Coronary venoplasty during cardiac resynchronization therapy device implantations: Acute results and clinical outcomes. Heart Rhythm. 17(5). 736–742. 2 indexed citations
7.
Sia, Ching‐Hui, Devinder Singh, & Joshua P. Loh. (2018). Can you interpret the ECG under stress?. Singapore Medical Journal. 59(9). 455–459. 2 indexed citations
8.
Tan, Eugene S.J., et al.. (2018). Optimal duration and predictors of diagnostic utility of patient-activated ambulatory ECG monitoring. Heart Asia. 10(2). e011061–e011061. 5 indexed citations
9.
Kojodjojo, Pipin, Elaine Boey, Xianyi Chen, et al.. (2016). Mapping clinical journeys of Asian patients presenting to the Emergency Department with syncope: Strict adoption of international guidelines does not reduce hospitalisations. International Journal of Cardiology. 218. 212–218. 1 indexed citations
10.
Seow, Swee‐Chong, et al.. (2014). Permanent pacing in patients without upper limb venous access: a review of current techniques. Heart Asia. 6(1). 163–166. 6 indexed citations
11.
Bhatia, Nidhi, et al.. (2013). Evaluation of analgesic effect of local administration of morphine after iliac crest bone graft harvesting: A double blind study. Journal of Anaesthesiology Clinical Pharmacology. 29(3). 356–356. 11 indexed citations
12.
Singh, Devinder, et al.. (2008). Incidental Diagnosis of Unicuspid Aortic Valve in an Asymptomatic Adult. Journal of the American Society of Echocardiography. 21(7). 876.e5–876.e5. 6 indexed citations
13.
Chopra, Kanwaljit, et al.. (2007). Role of α 2 Receptors in Quercetin-Induced Behavioral Despair in Mice. Journal of Medicinal Food. 10(1). 165–168. 18 indexed citations
14.
Singh, Devinder, et al.. (2006). Antioxidants in the Prevention of Renal Disease. Journal of Medicinal Food. 9(4). 443–450. 57 indexed citations
15.
Singh, Devinder, et al.. (2005). Participation of α 2 Receptors in the Antinociceptive Activity of Quercetin. Journal of Medicinal Food. 8(4). 529–532. 32 indexed citations
16.
Singh, Devinder, Vikas Chander, & Kanwaljit Chopra. (2004). Cyclosporine protects against ischemia/reperfusion injury in rat kidneys. Toxicology. 207(3). 339–347. 56 indexed citations
17.
Chander, Vikas, Devinder Singh, & Kanwaljit Chopra. (2004). Reversal of Experimental Myoglobinuric Acute Renal Failure in Rats by Quercetin, a Bioflavonoid. Pharmacology. 73(1). 49–56. 26 indexed citations
18.
Singh, Devinder, Vikas Chander, & Kanwaljit Chopra. (2004). Quercetin, a Bioflavonoid, Attenuates Ferric Nitrilotriacetate‐Induced Oxidative Renal Injury in Rats. Drug and Chemical Toxicology. 27(2). 145–156. 23 indexed citations
19.
Singh, Devinder, Vikas Chander, & Kanwaljit Chopra. (2003). Carvedilol, an Antihypertensive Drug with Antioxidant Properties, Protects against Glycerol-Induced Acute Renal Failure. American Journal of Nephrology. 23(6). 415–421. 26 indexed citations
20.
Jackson, Randy W., Richard Gelinas, Thomas C. Cox, et al.. (2002). Benzobicyclooctanes as novel inhibitors of TNF-α signaling. Bioorganic & Medicinal Chemistry Letters. 12(7). 1093–1097. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026